A comparative experimental study of the effects of diclofenac and ketoprofen on the small-bowel mucosa of canines

Research in Experimental Medicine

Volumn 200, Issue 2, 2001, Pages 125-135

  Baltoyiannis, George ^a   Christodoulos, Nathanael ^a   Mitsis, Michael ^a   Stephanou, Dimitris ^a   Ioannou, Hristos ^a   Nousias, Vasilios ^a   Kappas, Angelos M ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Bowel mucosa; Diclofenac; Ketoprofen; Lesions; NAIDs

Indexed keywords

DICLOFENAC; KETOPROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG EXCRETION; DRUG HALF LIFE; HISTOPATHOLOGY; LYSOSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; SMALL INTESTINE MUCOSA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOGS; INTESTINAL MUCOSA; INTESTINE, SMALL; KETOPROFEN;

EID: 0035147245     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03220020     Document Type: Article

References (30)

1. Utilization of non-steroidal anti-inflammatory drugs
2. Rare adverse reactions to non-steroidal anti-inflammatory drugs
3. Anti-arthritis medication usage: United States, 1991
4. Non-steroidal anti-inflammatory drug induced intestinal inflammation in humans
5. Gastrointestinal damage associated with the use of non-steroidal anti-inflammatory drugs
6. Non-steroidal anti-inflammatory drug gastropathy: We start it, can we stop it?
7. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy: Double blind long-term evaluation
8. Protection of the gastroduodenal mucosa from the effects of diclofenac sodium: Role of highly selective vagotomy and misoprostol
9. International guiding principles for biomedical research involving animals
10. Indomethacin-induced intestinal inflammation
11. The changing gastrointestinal side profile of nonsteroidal anti-inflammatory drugs. A new approach for the prevention of a new problem
12. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs
13. Non-steroidal anti-inflammatory drugs-differences and similarities
14. Diffusion of intramuscular ketoprofen into cerebrospinal fluid
15. 111-indium labeled polymorphonuclear leucocyte scans in rheumatoid arthritis - An important clinical cause of false positive results
16. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis?
17. Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs
18. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss
19. Diaphragm disease: Pathology of the small intestine induced by non-steroidal anti-inflammatory drugs
20. Small intestinal ulcers and intestinal flora in rats given indomethacin
21. Protective mechanisms of the gastric mucosa
22. Non steroidal anti-inflammatory drug gastropathy and cytoprotection: Pathogenesis and mechanisms re-examined
23. Enterohepatic circulation of indomethacin and its role in intestinal irritation
24. Role of bacteria in gastric ulceration produced by indomethacin in the rat cytoprotective action of antibiotics
25. Recent insight into the mechanism of gastrointestinal tract ulceration
26. Safety of ketoprofen in the elderly: A prospective study on 20000 patients
27. An analysis of the gastrointestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species
28. The importance of local versus systemic effects of non-steroidal anti-inflammatory drugs to increase intestinal permeability in man
29. The biochemical basis of non steroidal anti inflammatory drug-induced damage to the gastrointestinal tract. A review and a hypothesis